For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

As of close of business last night, ENDRA Life Sciences Inc’s stock clocked out at $4.34, up 1.88% from its previous closing price of $4.26. In other words, the price has increased by $1.88 from its previous closing price. On the day, 0.59 million shares were traded. NDRA stock price reached its highest trading level at $4.65 during the session, while it also had its lowest trading level at $4.01.

Ratios:

To gain a deeper understanding of NDRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.26.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 27 ’24 when UBS Group AG bought 3,715 shares for $0.55 per share. The transaction valued at 2,052 led to the insider holds 146,012 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NDRA now has a Market Capitalization of 3266956 and an Enterprise Value of 1726954.

Stock Price History:

The Beta on a monthly basis for NDRA is -0.12, which has changed by -0.9557143 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, NDRA has reached a high of $127.75, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -11.52%, while the 200-Day Moving Average is calculated to be -15.29%.

Shares Statistics:

It appears that NDRA traded 1.62M shares on average per day over the past three months and 93770 shares per day over the past ten days. A total of 0.75M shares are outstanding, with a floating share count of 0.75M. Insiders hold about 0.02% of the company’s shares, while institutions hold 0.24% stake in the company. Shares short for NDRA as of 1752537600 were 232753 with a Short Ratio of 0.14, compared to 1749772800 on 16935. Therefore, it implies a Short% of Shares Outstanding of 232753 and a Short% of Float of 30.919999999999998.

Earnings Estimates

The current assessment of ENDRA Life Sciences Inc (NDRA) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$2.67, with high estimates of -$2.67 and low estimates of -$2.67.

Analysts are recommending an EPS of between -$9.6 and -$9.6 for the fiscal current year, implying an average EPS of -$9.6. EPS for the following year is -$10.0, with 1.0 analysts recommending between -$10.0 and -$10.0.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $300k in the next fiscal year. The high estimate is $300k and the low estimate is $300k.